Kyle A Perry, MD
College of Medicine
>Gastroesophageal Reflux ● Cancer ● Esophageal Cancer ● Inflammation ● Esophageal Achalasia ● Carcinoma ● Deglutition Disorders ● Pheochromocytoma
Kyle Perry, MD, is a member of the Translational Therapeutics Program at the OSUCCC – James, where his research focuses on prevention, surgical treatment and outcome improvement of esophageal, gastric and pancreatic cancers.In particular, he works on in vivo studies to improve surgical techniques and patient outcomes. He also studies cancer prevention through the treatment of Barrett esophagus. One of his recent studies indicates that intramucosal cancer can be managed endoscopically, eliminating the need for esophagectomies in a significant number of patients. Dr. Perry has co-authored numerous articles in well-known publications, including Surgical Endoscopy and Minerva Chirurgica.